GO:0043604 | amide biosynthetic process | 10.66% (26/244) | 3.25 | 0.0 | 0.0 |
GO:0043043 | peptide biosynthetic process | 10.66% (26/244) | 3.25 | 0.0 | 0.0 |
GO:0003735 | structural constituent of ribosome | 10.66% (26/244) | 3.25 | 0.0 | 0.0 |
GO:0006412 | translation | 10.66% (26/244) | 3.26 | 0.0 | 0.0 |
GO:0005198 | structural molecule activity | 11.07% (27/244) | 3.21 | 0.0 | 0.0 |
GO:0005840 | ribosome | 10.25% (25/244) | 3.26 | 0.0 | 0.0 |
GO:0006518 | peptide metabolic process | 10.66% (26/244) | 3.16 | 0.0 | 0.0 |
GO:0034645 | cellular macromolecule biosynthetic process | 10.66% (26/244) | 3.14 | 0.0 | 0.0 |
GO:0043603 | amide metabolic process | 10.66% (26/244) | 3.14 | 0.0 | 0.0 |
GO:1901566 | organonitrogen compound biosynthetic process | 11.48% (28/244) | 2.94 | 0.0 | 0.0 |
GO:0043232 | intracellular non-membrane-bounded organelle | 10.25% (25/244) | 3.19 | 0.0 | 0.0 |
GO:0043228 | non-membrane-bounded organelle | 10.25% (25/244) | 3.19 | 0.0 | 0.0 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 11.48% (28/244) | 2.82 | 0.0 | 0.0 |
GO:0009059 | macromolecule biosynthetic process | 10.66% (26/244) | 2.87 | 0.0 | 0.0 |
GO:0044249 | cellular biosynthetic process | 11.89% (29/244) | 2.52 | 0.0 | 0.0 |
GO:0043226 | organelle | 10.66% (26/244) | 2.72 | 0.0 | 0.0 |
GO:0043229 | intracellular organelle | 10.66% (26/244) | 2.72 | 0.0 | 0.0 |
GO:0044260 | cellular macromolecule metabolic process | 10.66% (26/244) | 2.7 | 0.0 | 0.0 |
GO:1901576 | organic substance biosynthetic process | 11.89% (29/244) | 2.43 | 0.0 | 0.0 |
GO:0009058 | biosynthetic process | 11.89% (29/244) | 2.31 | 0.0 | 0.0 |
GO:0034641 | cellular nitrogen compound metabolic process | 11.48% (28/244) | 2.14 | 0.0 | 0.0 |
GO:0005575 | cellular_component | 15.57% (38/244) | 1.63 | 0.0 | 0.0 |
GO:0019538 | protein metabolic process | 12.7% (31/244) | 1.78 | 0.0 | 0.0 |
GO:1901564 | organonitrogen compound metabolic process | 13.52% (33/244) | 1.58 | 0.0 | 0.0 |
GO:0043170 | macromolecule metabolic process | 12.7% (31/244) | 1.38 | 1e-06 | 1.3e-05 |
GO:0110165 | cellular anatomical entity | 11.48% (28/244) | 1.46 | 1e-06 | 1.6e-05 |
GO:0006807 | nitrogen compound metabolic process | 13.52% (33/244) | 1.3 | 2e-06 | 1.9e-05 |
GO:0044238 | primary metabolic process | 14.75% (36/244) | 1.18 | 4e-06 | 4.1e-05 |
GO:0071704 | organic substance metabolic process | 14.75% (36/244) | 1.09 | 1.5e-05 | 0.000145 |
GO:0044237 | cellular metabolic process | 12.3% (30/244) | 1.18 | 2.8e-05 | 0.000263 |
GO:0008152 | metabolic process | 15.16% (37/244) | 0.99 | 4.7e-05 | 0.000432 |
GO:0009987 | cellular process | 15.16% (37/244) | 0.93 | 0.000112 | 0.000968 |
GO:0008234 | cysteine-type peptidase activity | 2.05% (5/244) | 3.42 | 0.000109 | 0.000971 |
GO:0008150 | biological_process | 20.08% (49/244) | 0.77 | 0.000128 | 0.001071 |
GO:0032991 | protein-containing complex | 4.1% (10/244) | 1.94 | 0.000331 | 0.002696 |
GO:0033176 | proton-transporting V-type ATPase complex | 0.82% (2/244) | 5.82 | 0.000513 | 0.003849 |
GO:0016469 | proton-transporting two-sector ATPase complex | 0.82% (2/244) | 5.82 | 0.000513 | 0.003849 |
GO:0016471 | vacuolar proton-transporting V-type ATPase complex | 0.82% (2/244) | 5.82 | 0.000513 | 0.003849 |
GO:1904949 | ATPase complex | 0.82% (2/244) | 5.4 | 0.000951 | 0.006947 |
GO:0098796 | membrane protein complex | 2.05% (5/244) | 2.39 | 0.002771 | 0.019743 |
GO:0006814 | sodium ion transport | 0.41% (1/244) | 7.4 | 0.005908 | 0.03436 |
GO:0016055 | Wnt signaling pathway | 0.41% (1/244) | 7.4 | 0.005908 | 0.03436 |
GO:0090533 | cation-transporting ATPase complex | 0.41% (1/244) | 7.4 | 0.005908 | 0.03436 |
GO:0006836 | neurotransmitter transport | 0.41% (1/244) | 7.4 | 0.005908 | 0.03436 |
GO:0005890 | sodium:potassium-exchanging ATPase complex | 0.41% (1/244) | 7.4 | 0.005908 | 0.03436 |
GO:0007166 | cell surface receptor signaling pathway | 0.41% (1/244) | 7.4 | 0.005908 | 0.03436 |
GO:1905114 | cell surface receptor signaling pathway involved in cell-cell signaling | 0.41% (1/244) | 7.4 | 0.005908 | 0.03436 |
GO:0005102 | signaling receptor binding | 0.41% (1/244) | 7.4 | 0.005908 | 0.03436 |
GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism | 0.82% (2/244) | 4.01 | 0.006778 | 0.036448 |
GO:0019829 | ATPase-coupled monoatomic cation transmembrane transporter activity | 0.82% (2/244) | 4.01 | 0.006778 | 0.036448 |
GO:0042625 | ATPase-coupled ion transmembrane transporter activity | 0.82% (2/244) | 4.01 | 0.006778 | 0.036448 |
GO:0046961 | proton-transporting ATPase activity, rotational mechanism | 0.82% (2/244) | 4.01 | 0.006778 | 0.036448 |
GO:0098797 | plasma membrane protein complex | 0.82% (2/244) | 4.16 | 0.005562 | 0.038665 |
GO:0015078 | proton transmembrane transporter activity | 1.23% (3/244) | 2.88 | 0.00801 | 0.042272 |
GO:0009142 | nucleoside triphosphate biosynthetic process | 0.82% (2/244) | 3.7 | 0.010289 | 0.048871 |
GO:0009201 | ribonucleoside triphosphate biosynthetic process | 0.82% (2/244) | 3.7 | 0.010289 | 0.048871 |
GO:0009145 | purine nucleoside triphosphate biosynthetic process | 0.82% (2/244) | 3.7 | 0.010289 | 0.048871 |
GO:0006754 | ATP biosynthetic process | 0.82% (2/244) | 3.7 | 0.010289 | 0.048871 |
GO:0009206 | purine ribonucleoside triphosphate biosynthetic process | 0.82% (2/244) | 3.7 | 0.010289 | 0.048871 |
GO:0015986 | proton motive force-driven ATP synthesis | 0.82% (2/244) | 3.7 | 0.010289 | 0.048871 |